Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1630 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Sophia Genetics–Alychlo: investment, 201901 financing round totalling $77m incl existing + co-investor Alychlo 2019-01-04
Sophia Genetics–Balderton Capital: investment, 201901 financing round totalling $77m incl existing + co-investor Balderton Capital 2019-01-04
Sophia Genetics–Generation Investment Management: investment, 201901 financing round totalling $77m incl new + lead investor Generation 2019-01-04
Sophia Genetics–Idinvest Partners: investment, 201901 financing round totalling $77m incl new + co-investor Idinvest Partners 2019-01-04
Sophia Genetics–SEVERAL: investment, 201901 financing round $77m incl new + lead investor Generation Investment Management LLP 2019-01-04
Vedanta Biosciences–BMS: investment, 201812 financing round Series C totalling $27m incl new investor BMS 2018-12-24
Vedanta Biosciences–BPCE: investment, 201812 financing round Series C totalling $27m incl existing investor Seventure Partners 2018-12-24
Vedanta Biosciences–Gates Foundation: investment, 201812 financing round Series C totalling $27m incl new investor Gates Foundation 2018-12-24
Vedanta Biosciences–Invesco: investment, 201812 financing round Series C totalling $27m incl existing investor Invesco Asset Management 2018-12-24
Vedanta Biosciences–PureTech Health: investment, 201812 financing round Series C totalling $27m incl existing investor PureTech Health 2018-12-24
Vedanta Biosciences–Rock Springs Capital: investment, 201812 financing round Series C totalling $27m incl existing investor Rock Springs Capital 2018-12-24
Vedanta Biosciences–SEVERAL: investment, 201812 financing round Series C $27m Gates + BMS + Rock Springs Capital + Invesco + Seventure + PureTech 2018-12-24
France (govt)–Novartis: investment, 201812– proposed acquisition of CellforCure from LFB by Novartis 2018-12-20
Carmat–EU (govt): credit, 201812– EFSI €30m loan from EIB to move artificial heart towards marketing 2018-12-17
Kurma–France (govt): investment, 201812 first closing of Kurma Biofund III incl cornerstone investors Servier + Bpifrance + Idinvest 2018-12-14
Kurma–Idinvest Partners: investment, 201812 first closing of Kurma Biofund III incl cornerstone investors Servier + Bpifrance + Idinvest 2018-12-14
Kurma–NewCap: public relations, 201812 service existent by NewCap 2018-12-14
Kurma–Servier: investment, 201812 first closing of Kurma Biofund III incl cornerstone investors Servier + Bpifrance + Idinvest 2018-12-14
Kurma–SEVERAL: investment, 201812 first closing of Kurma Biofund III with target for final closing of €150m 2018-12-14
Pharvaris–Kurma: investment, 201812 existing founding investor Kurma Biofund II 2018-12-14
Step Pharma–Kurma: investment, 201812 existing founding investor Kurma Biofund II 2018-12-14
genOway–Merck (DE): CRISPR technology, 201812– collab strategic alliance €na incl ww excl license to produce + sell genome-edited rodent models 2018-12-10
Hookipa–Valneva: drug development services, 201812–202111 collab + manufacturing agreem for developm of immunotherapies with Valneva Sweden AB 2018-12-06
Sillages Paris–L’Oréal: investment, 201812 acquisition of minority share by BOLD fund as inaugural investment of BOLD 2018-12-05
Anagenesis–Alsace (govt): investment, 201812 financing round Series A 1st closing totalling €3m incl existing investor Cap Innov’Est 2018-12-04
Anagenesis–Boehringer: investment, 201812 financing round Series A 1st closing totalling €3m incl new investor BIVF 2018-12-04
Anagenesis–SEVERAL: investment, 201812 financing round Series A €3m 1st closing from BIVF + Cap Innov’Est 2018-12-04
Boehringer–Domain Therapeutics: drug discovery services, 201812– collab + license agreem €na discovery of GPCR-targeting CNS drugs 2018-12-04
Celyad–Bryan Garnier: investor conference, 201811 supply service Celyad participates at Bryan Garnier Annual Healthcare Conference in Paris 2018-11-22
Erytech–Infopro Digital: investor conference, 201811 supply service Erytech at Actionaria 2018 in Paris 2018-11-22
Stilla Technologies–Alize RP: public relations, 201811 service existent PR EU by Alize RP 2018-11-20
Stilla Technologies–BNP Paribas: investment, 201811 financing round Series A totalling €16m incl co-investor BNP Paribas Développement 2018-11-20
Stilla Technologies–Idinvest Partners: investment, 201811 financing round Series A totalling €16m incl co-investor Idinvest Partners 2018-11-20
Stilla Technologies–Illumina: investment, 201811 financing round Series A totalling €16m incl lead investor Illumina Ventures 2018-11-20
Stilla Technologies–Kurma: investment, 201811 financing round Series A totalling €16m incl co-investor Kurma Partners 2018-11-20
Stilla Technologies–LBO France: investment, 201811 financing round Series A totalling €16m incl co-investor LBO France 2018-11-20
Stilla Technologies–Paris Saclay Seeds: investment, 201811 financing round Series A totalling €16m incl co-investor Paris Saclay Seeds 2018-11-20
Stilla Technologies–SEVERAL: investment, 201811 financing round Series A €16m led by Illumina Ventures 2018-11-20
Erytech–Leucadia: investor conference, 201811 supply service Erytech at Jefferies London Healthcare Conference 2018 2018-11-14
IntegraGen–Alphabet: bioinformatics, 201811 collab implementation of Sirius + Mercury genomic analsys tools in Google Cloud 2018-11-12
Sanofi–Denali Therapeutics: RIPK1 inhibitors, 201811– collab $125m upfront + >$1b + royalties RIPK1 inhibitors incl DNL 747 + DNL 758 2018-11-01
Magnisense–SEVERAL: investment, 201810 financing round €5m from new + existing investors incl Meusinvest + Provestis + Concorde Capital + Minv 2018-10-24
Microbiotica–BPCE: investment, 201810 investment £4m by Seventure Partners’ Health for Life Capital Fund 2018-10-24
Acticor Biotech–CapDecisif: investment, 201810 financing round Series B totalling €15.3m incl existing + co-investor CapDecisif Management (HK) 2018-10-17
Acticor Biotech–China Medical System: investment, 201810 financing round Series B totalling €15.3m incl new + co-investor CMS Medical Venture 2018-10-17
Acticor Biotech–Mirae Asset: investment, 201810 financing round Series B totalling €15.3m incl new + co-investor Mirae Asset Capital Co Ltd 2018-10-17
Acticor Biotech–NewCap: public relations, 201810 service existent by NewCap 2018-10-17
Acticor Biotech–Newton Biocapital: investment, 201810 financing round Series B totalling €15.3m incl new + lead investor Newton Biocapital 2018-10-17
Acticor Biotech–PERSON: investment, 201810 financing round Series B totalling €15.3m incl new + co-investor A&B (HK) 2018-10-17
Acticor Biotech–SEVERAL: investment, 201810 financing round Series B €15.3m led by new investor Newton Biocapital 2018-10-17
Erytech–EZIL: investor conference, 201810 supply service Erytech at European Large & Midcap Event in Paris 2018-10-09
Rgenix–SEVERAL: investment, 201810 financing round Series C $40m led by Lepu Medical + incl Novo Holdings + Sofinnova Partners et al 2018-10-09
Sanofi–Evotec: drug discovery, 201810– collab partnership BRIDGE LAB031 for early-stage projects out of academic research 2018-10-04
Sartorius–Genedata: bioinformatics, 201810 collab product integration of Genedata Bioprocess s/w with ambr mini bioreactos 2018-10-02
JSTI Group–Eurofins: investment, 201810– acquisition $175m cash+debt free of TestAmerica by Eurofins from JSTI Group (CN) 2018-10-01
Sanofi–Advent International: investment, 201804–201810 acquisition €1.9b (enterprise value) of Sanofi’s European generics business Zentiva by Advent 2018-10-01
Genewiz–Brooks Automation: investment, 201809– acquisition $450m of Genewiz by Brooks ANNOUNCED 2018-09-26
Minoryx–SEVERAL: investment, 201809 financing round Series B €21.3m led by Fund+ with SFPI + SRIW + Sambrinvest + all Series A investors 2018-09-26
Valneva–SEVERAL: investment, 201809 private placement €50m with 13.33m new ordinary shares at €3.75/share led by US healthcare investors 2018-09-26
Axenis–genOway: investment, 201809 acquisition of Axenis SAS by genOway SA 2018-09-25
GeNeuro–Servier: investment, 201809 existent investor Servier 2018-09-18
Horama–V-Bio Ventures: investment, 201809 Series B investment €3.5m by V-Bio bringing total Series B round to €22.5m 2018-09-18
GamaMabs Pharma–Andrew Lloyd Associates: public relations, 201809 service existent by ALA 2018-09-17
Applied Microarrays–Novacyt: DNA microarrays, 201809– €na collab developm probes for customised SNP microarrys by Primerdesign 2018-09-13
Erytech–Morgan Stanley: investor conference, 201809 supply service Erytech presents at Morgan Stanley Global Healthcare Conference NY 2018-09-13
Celgene–Evotec: drug discovery services, 201809– strategic RnD collab in field of targeted protein degradation using Panomics platform 2018-09-06
Genkyotex–Yorkville Group: credit, 201808– up to €7.5m convertible notes with attached warrants in 2 tranches with YA II PN Ltd 2018-08-20
Artios Pharma–AbbVie: investment, 201808 financing round Series B totalling $84m incl existing + co-investor AbbVie Ventures 2018-08-10
Artios Pharma–Andera Partners: investment, 201808 financing round Series B totalling $84m (£65m) incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Arix Bioscience: investment, 201808 financing round Series B totalling $84m incl existing + co-investor Arix Bioscience 2018-08-10
Artios Pharma–IP Group: investment, 201808 financing round Series B totalling $84m incl existing + co-investor IP Group 2018-08-10
Artios Pharma–Life Sciences Partners: investment, 201808 financing round Series B totalling $84m incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Merck (DE): investment, 201808 financing round Series B totalling $84m incl existing + co-investor M Ventures 2018-08-10
Artios Pharma–Novartis: investment, 201808 financing round Series B totalling $84m incl new + co-investor Novartis Venture Fund 2018-08-10
Artios Pharma–Pfizer: investment, 201808 financing round Series B totalling $84m incl new + co-investor Pfizer Ventures 2018-08-10
Artios Pharma–SEVERAL: investment, 201808 financing round Series B $84m (£65m) led by new investors Andera Partners + LSP 2018-08-10
Artios Pharma–SV Health Investors: investment, 201808 financing round Series B totalling $84m incl existing + co-investor SV 2018-08-10
ReViral–Andera Partners: investment, 201808 financing round Series B totalling $55m incl existing + co-investor Andera Partners 2018-08-01
ReViral–EMS (BR): investment, 201808 financing round Series B totalling $55m incl existing + co-investor Brace Pharma Capital 2018-08-01
ReViral–OrbiMed Advisors: investment, 201808 financing round Series B totalling $55m incl existing + co-investor OrbiMed 2018-08-01
ReViral–SEVERAL: investment, 201808 financing round Series B $55m co-lead by new investors New Leaf Venture Partners + Novo Ventures 2018-08-01
Laboratorios Ecosur–Eurofins: investment, 201807 acquisition of Ecosur by Eurofins 2018-07-27
Nanobiotix–EU (govt): credit, 201807– up to €40m loan agreement with EIB over coming five years subjet to performance criteria 2018-07-26
Abivax–Kreos Capital: credit, 201807– debt financing up to €20m in 2 tranches with attached up to €1.6m warrants 2018-07-25
TxCell–Sangamo: investment, 201807– acquisiton $72m in cash on cash/debt-free basis with simplified cash tender offer 2018-07-23
Adocia–MC Services: public relations, 201807 service existent PR Europe by MC Services 2018-07-18
Adocia–Ruth Group: public relations, 201807 service existent IR USA by The Ruth Group 2018-07-18
Sanofi–Revolution Medicines: SHP2 inhibitors, 201807– collab ww to develop SHP2 inhibitors incl RMC-4630 for multiple cancers 2018-07-18
Sohin (MX)–HalioDx: cancer test, 201807– distribution of Immunoscore Colon Assay in Mexico by Sohin 2018-07-16
Antabio–SEVERAL: investment, 201807 2nd closing financing round Series A €5.2m bringing total Series A to €12.5m 2018-07-12
Institut Pasteur–Thermo Fisher: transmission electron microscope, 201807 supply Krios Cryo-TEM system to Institut Pasteur in Paris 2018-07-12
Miltenyi Biotec–Scienion: cell handling technology, 201807– collab co-marketing MACSQuant Tyto Cell Sorter with cellenONE X1 Cell Dispenser 2018-07-12
Omnes Capital–Brackendale Consulting: public relations, 201807 service existent by Brackendale Consulting 2018-07-12
Yposkesi–Andrew Lloyd Associates: public relations, 201807 service existent by ALA 2018-07-09
Dynacure–Andera Partners: investment, 201807 financing round totalling €47m incl lead investor Andera Partners 2018-07-06
Dynacure–France (govt): investment, 201807 financing round totalling €47m incl co-investor Bpifrance 2018-07-06
Dynacure–Idinvest Partners: investment, 201807 financing round totalling €47m incl co-investor Idinvest Partners 2018-07-06
Dynacure–Kurma: investment, 201807 financing round totalling €47m incl co-investor Kurma Partners 2018-07-06
Dynacure–Pontifax: investment, 201807 financing round totalling €47m incl co-investor Pontifax 2018-07-06
Dynacure–SEVERAL: investment, 201807 financing round €47m led by Andera Partners + incl Pontifax + Bpifrance + Kurma + IdInvest 2018-07-06
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top